Denovo Biopharma Announces a Major Breakthrough in Treatment‑Resistant Depression with Precision Medicine streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Denovo Biopharma LLC: Denovo Biopharma Announces a Major Breakthrough in Treatment-Resistant Depression with Precision Medicine finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
The Monarch eTNS device is a digital therapy for children with ADHD ages 7 to 12 that sends low stimulating pulses to the trigeminal nerve through a disposable patch on the forehead.